Transforming growth factor beta and the cell surface in tumor progression

Cancer and Metastasis Reviews

Volumn 12, Issue 3-4, 1993, Pages 239-254

  Newman, Michael J ^a  

^a Sandoz Pharma Ltd   (Switzerland)

Author keywords

collagen; EGF; extracellular matrix; membrane traffic; TGF 1

Indexed keywords

COLLAGEN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR RECEPTOR; PROTEIN KINASE C; TRANSFORMING GROWTH FACTOR BETA1;

CANCER CHEMOTHERAPY; CANCER GROWTH; CARCINOMA; CELL GROWTH; CELL SURFACE; EXTRACELLULAR MATRIX; GROWTH INHIBITION; GROWTH REGULATION; GROWTH STIMULATION; HUMAN; MELANOMA; PRIORITY JOURNAL; REVIEW;

ANIMAL; CELL DIVISION; CELL MEMBRANE; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; FIBROBLASTS; HUMAN; NEOPLASMS; SUPPORT, NON-U.S. GOV'T; TRANSFORMING GROWTH FACTOR BETA;

EID: 0027429282     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/BF00665956     Document Type: Article

References (104)

1. Tumor suppressor genes
2. Molecular themes in oncogenesis
3. Oncogenes and signal transduction
4. Growth factors in development, transformation, and tumorigenesis
5. Growth factors and cancer
6. The transforming growth factor-β family
7. Transforming growth factor-β
8. The transforming growth factor-βs. In: Peptide growth factors and their receptors/Handbook of Experimental Pharmacology
9. Transforming growth factors and the regulation of cell proliferation
10. Distribution of cells expressing myc proteins in human colorectal eipthelium, polyps, and malignant tumors
11. Evaluation of the role of extracellular matrix proteins, polyunsaturated fatty acids and c- myc expression in the inhibition of the serum-free growth of epithelial cells by TGF-β1
12. Loss of transforming growth factor beta 1 (TGF-beta 1)-induced growth arrest and p34cdc2 regulation in ras-transfected epithelial cells
13. Transcriptional activation of the c-myc proto-oncogene in murine keratinocytes enhances the response to epidermal growth factor
14. Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation
15. Transforming growth factor β1 (TGFβ1) reduces cellular levels of p34cdc2, and this effect is abrogated by adenovirus independently of the E1A-associated pRB binding activity
16. Early gene responses to transforming growth factor-β in cells lacking growth-suppressive RB function
17. Differential effects of transforming growth factor β on human prostate cancer cells in vitro
18. Isolation of a prostate carcinoma cell proliferation-inhibiting factor from human seminal plasma and its similarity to transforming growth factor β
19. Inactivation of the retinoblastoma gene does not lead to loss of TGF-β receptors or response to TGF-β in breast cancer cell lines
20. Mutant p53 can induce tumorigenic conversion of human bronchial epithelial cells and reduce their responsiveness to a negative growth factor, transforming growth factor beta 1
21. Mutant p53 tumor suppressor gene causes resistance to transforming growth factor beta 1 in murine keratinocytes
22. Cytokines in context
23. TGF-β: regulation of extracellular matrix
24. TGF-beta and extracellular matrix related influences on gene expression and phenotype
25. Inhibition of normal rat kidney cell growth by transforming growth factor-β is mediated by collagen
26. Signal transduction from the extracellular matrix
27. Control of growth and differentiation of vascular cells by extracellular matrix proteins
28. Determination of cellular shape by the extracellular matrix and its correlation with the control of cellular growth
29. Transcriptional suppression of cellular gene expression by c-Myc
30. Collagen synthesis in fibroblasts transformed by oncogenic viruses
31. Synthesis of collagen by human fibroblasts and their SV40 transformants
32. Characterization of collagen synthesized by normal and chemically transformed rat liver epithelial cell lines
33. Mechanisms of Kirsten murine sarcoma virus transformation-induced changes in the collagen phenotype and synthetic rate of BALB 3T3 cells
34. Transformation-dependent alterations in glycoproteins of the extracellular matrix of human fibroblasts
35. Absence of procollagen alpha 2(I) mRNA in chemically transformed rat liver epithelial cells
36. Pleiotropic mutants of NIH 3T3 cells with altered regulation in the expression of both type I collagen and fibronectin
37. Regulation of collagen gene expression
38. Regulation of collagen I gene expression by ras
39. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation
40. Tumor cell adhesion to the extracellular matrix and signal transduction mechanisms implicated in tumor cell motility, invasion and metastasis
41. Expression of multi-cytokine resistance and multi-growth factor independence in advanced stage metastatic cancer: malignant melanoma as a paradigm
42. Development of resistance mechanisms to the growth-inhibitory effects of transforming growth factor-beta during tumor progression
43. Loss of growth inhibition by transforming growth factor-beta-1 (TGF-beta-1) and aberrant expression of alpha 2 type I collagen in spontaneously transformed and virus-transformed normal rat kidney cells (Abstract). Meeting On Wound Repair Held At The 20Th Annual Meeting Of The Keystone Symposia On Molecular And Cellular Biology, Keystone, Colorado, USA, April 1–7, 1991
44. Induction of anchorage-independent growth by epidermal growth factor and altered sensitivity to type β transforming growth factor in partially transformed rat kidney cells
45. Growth stimulation, altered regulation of epidermal growth factor receptors, and autocrine transformation of spontaneously transformed normal rat kidney cells by transforming growth factor β
46. Characterization and purification of a secreted plasminogen activator inhibitor (PAI-1) induced by transforming growth factor-β1 in normal rat kidney (NRK) cells: decreased PAI-1 expression in transformed NRK cells
47. Aberrant TGF-beta production and regulation in metastatic malignancy
48. Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor beta: a proposed model for indirect mitogenesis involving autocrine activity
49. TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop
50. New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues
51. Insulin-like synergistic stimulation of DNA synthesis in Swiss 3T3 cells by the BSC-1 cell-derived growth inhibitor related to transforming growth factor type beta
52. Transforming growth factor β1 is a powerful modulator of platelet-derived growth factor action in vascular smooth muscle cells
53. Type β transforming growth factor: a bifunctional regulator of cellular growth
54. Transforming growth factor-β controls receptor levels for epidermal growth factor in NRK fibroblasts
55. Transforming growth factor-β modulates the high-affinity receptors for epidermal growth factor and transforming growth factor-α
56. TGF-β inhibition of endothelial cell proliferation: alteration of EGF binding and EGF-induced growth-regulatory (competence) gene expression
57. Stimulation by transforming growth factor-β of epidermal growth factor-dependent growth of aged human fibroblasts: recovery of high affinity EGF receptors and growth stimulation by EGF
58. Transforming growth factor β1 inhibits epidermal growth factor receptor endocytosis and down-regulation in cultured fetal rat hepatocytes
59. Biphasic effects of type β transforming growth factor on epidermal growth factor receptors in NRK fibroblasts
60. Role of transforming growth factor-β in repair and fibrosis
61. The role of transforming growth factor-beta in inflammatory processes
62. Wound repair: a review
63. Direct evidence for spatial and temporal regulation of transforming growth factor β1 expression during cutaneous wound healing
64. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing
65. Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor β1
66. Transforming growth factor β1 can induce estrogen-independent tumorigenicity of human breast cancer cells in athymic mice
67. Transforming growth factor β stimulates mammary adenocarcinoma cell invasion and metastatic potential
68. Excessive production of transforming growth-factor β1 can play an important role in the development of tumorigenesis by its action for angiogenesis: validity of neutralizing antibodies to block tumor growth
69. Mediation of wound-related Rous sarcoma virus tumorigenesis by TGF-β
70. A highly immunogenic tumor transfected with a murine transforming growth factor type β1 cDNA escapes immune surveillance
71. Immunodetection and modulation of cellular growth with antibodies against native transforming growth factor-β
72. The epidermal growth factor receptor as a multifunctional allosteric protein
73. Ligand-induced transformation by a noninternalizing epidermal growth factor receptor
74. Transformation by murine and feline sarcoma viruses specifically blocks binding of epidermal growth factor to cells
75. Growth factors from murine sarcoma virus-transformed cells
76. Nonfunctional epidermal growth factor receptor in cells transformed by kirsten sarcoma virus
77. Platelet-derived growth factor in autocrine transformation
78. Rapid, complete and reversible transformation by v- sis precedes irreversible transformation
79. Autocrine regulation of cell growth and transformation by basic fibroblast growth factor
80. Heterologous regulation of EGF receptors in fibroblastic cells
81. Resolution of high and low affinity epidermal growth factor receptors. Inhibition of high affinity component by low temperature, cycloheximide, and phorbol esters
82. Regulation of receptor-mediated endocytosis by phorbol esters
83. Release of a phorbol ester-induced mitogenic block by mutation at Thr-654 of the epidermal growth factor receptor
84. Multisite phosphorylation of the epidermal growth factor receptor. Use of site-directed mutagenesis to examine the role of serine/threonine phosphorylation
85. Phorbol esters induce transient internalization without degradation of unoccupied epidermal growth factor receptors
86. Receptors for the TGF-beta family
87. Protein kinase C and non-functional EGF receptor in K-ras transformed cells
88. Transforming growth factor beta activates protein kinase C in microvessels isolated from immature rat brain
89. Transforming growth factor-beta: signal transduction via protein kinase C in cultured embryonic vascular smooth muscle cells
90. Role of heterotrimeric G proteins in membrane traffic
91. ‘Crosstalk’: a pivotal role for protein kinase C in modulating relationships between signal transduction pathways
92. Repression of autocrine transforming growth factor β1 and β2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties
93. Interleukin 6: a fibroblastderived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression
94. Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression
95. Bombesin-like peptides can fuction as autocrine growth factors in human small-cell lung cancer
96. Modulation of the epidermal growth factor receptor by mitogenic ligands: effects of bombesin and role of protein kinase C
97. Response of cultured mammalian cells to diphtheria toxin. IV. Isolation of KB cells resistant to diphtheria toxin
98. Mutant Chinese hamster ovary cells pleiotropically defective in receptor-mediated endocytosis
99. Defective acidification of endosomes in Chinese hamster ovary cell mutants ‘cross-resistant’ to toxins and viruses
100. A single mutation in Chinese hamster ovary cells impairs both Golgi and endosomal functions
101. Inhibition of carcinoma and melanoma cell growth by type 1 transforming growth factor β is dependent on the presence of polyunsaturated fatty acids
102. Malignant transformation is correlated with acquisition of sensitivity to transforming growth factor beta-1 and polyunsaturated fatty acid-mediated cytotoxicity (Abstract). 83Rd Annual Meeting Of The American Association For Cancer Research, San Diego, California, USA, May 20–23, 1992
103. Platelet-derived growth factor. I. High yield purification and evidence for multiple forms